Brief: Glenmark, Sun Pharma and Cipla said to weigh bid for Teva portfolio - Bloomberg
Nov 18 (Reuters) - * Glenmark, Sun Pharma Cipla said to weigh bid for Teva portfolio - Bloomberg, citing sources * Novartis AG's generics unit sandoz is also among about 30 companies weighing offers for teva's portfolio of U.S. generic products - Bloomberg * Source :(http://bloom.bg/1HZ0aeL) ((Bengaluru Newsroom; +1 646 2238780))
Recent news on Sun Pharma Advanced Research
See all newsAdvisory: Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
Brief: Sun Pharma Advanced Research Appoints Anil Raghavan As MD And CEO Effective August 11
Brief: Sun Pharma Advanced Research Says Ocuvex Therapeutics Gets Complete Response Letter For PDP-716 NDA
India's Sun Pharma Advanced Research jumps after swinging to Q4 profit
Brief: Sun Pharma Advanced Research March-Quarter Consol Profit 17.61 Billion Rupees